Pages that link to "Q24813664"
Jump to navigation
Jump to search
The following pages link to Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition (Q24813664):
Displaying 50 items.
- Gene therapy in Parkinson's disease: rationale and current status (Q22241423) (← links)
- The role of oxidative stress in Parkinson's disease (Q24307946) (← links)
- TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's disease (Q26747606) (← links)
- Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation (Q26771536) (← links)
- Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases (Q26827146) (← links)
- The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease (Q26853537) (← links)
- Microglial pathology (Q26992285) (← links)
- M1 and M2 immune activation in Parkinson's Disease: Foe and ally? (Q27024667) (← links)
- Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity (Q27027973) (← links)
- Parkinson's disease as a result of aging (Q28084395) (← links)
- Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance (Q28392011) (← links)
- Alpha-synuclein expression modulates microglial activation phenotype (Q28506842) (← links)
- Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants (Q30991616) (← links)
- Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons (Q33312931) (← links)
- Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease. (Q33526342) (← links)
- Brainstem pathology in spasmodic dysphonia (Q33556047) (← links)
- The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase-2 on Extracellular α-Synuclein Aggregates in Parkinsonian Models (Q33722313) (← links)
- White matter damage and systemic inflammation in Parkinson's disease (Q33781574) (← links)
- Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases (Q34014053) (← links)
- Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies (Q34576478) (← links)
- Oxidative stress and the pathogenesis of neurodegenerative disorders (Q34659807) (← links)
- Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation (Q35043731) (← links)
- Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP ) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade. (Q35416073) (← links)
- α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation (Q35484552) (← links)
- Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. (Q35510197) (← links)
- Microglia activation in sepsis: a case-control study (Q35612988) (← links)
- Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein (Q35621972) (← links)
- Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease (Q35626938) (← links)
- NF-κB in Aging and Disease (Q35806773) (← links)
- The Interplay between Alpha-Synuclein Clearance and Spreading (Q35833984) (← links)
- Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study (Q35884924) (← links)
- Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis (Q38634960) (← links)
- Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy (Q35960407) (← links)
- Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase (Q36156588) (← links)
- Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson's disease (Q36337052) (← links)
- The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. (Q36409902) (← links)
- Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation (Q36453886) (← links)
- Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? (Q36902290) (← links)
- Oxidative and inflammatory pathways in Parkinson's disease (Q37117681) (← links)
- Immunological features of alpha-synuclein in Parkinson's disease (Q37232067) (← links)
- Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration (Q37270004) (← links)
- Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease (Q37331433) (← links)
- Molecular and cellular biology of synucleins (Q37350413) (← links)
- Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4 CD25 T cells (Q37355257) (← links)
- Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinase (Q37362513) (← links)
- Morphometric characterization of microglial phenotypes in human cerebral cortex (Q37532369) (← links)
- Life and death of microglia (Q37579740) (← links)
- Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease (Q37612968) (← links)
- Bone fracture exacerbates murine ischemic cerebral injury (Q37704621) (← links)
- Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application (Q37779740) (← links)